Cargando…
A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
The present study aimed to identify the risk factors influencing the survival of patients with hepatocellular carcinoma (HCC) affected by portal vein tumor thrombus (PVTT), following hepatic resection, and to establish a prognostic model. Between March 2001 and May 2008, 234 cases of HCC with PVTT t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665632/ https://www.ncbi.nlm.nih.gov/pubmed/26722243 http://dx.doi.org/10.3892/ol.2015.3677 |
_version_ | 1782403606520004608 |
---|---|
author | XIAO, CHENG-ZUO WEI, WEI GUO, ZHI-XING LI, SHU-HONG ZHANG, YONG-FA WANG, JIA-HONG SHI, MING GUO, RONG-PING |
author_facet | XIAO, CHENG-ZUO WEI, WEI GUO, ZHI-XING LI, SHU-HONG ZHANG, YONG-FA WANG, JIA-HONG SHI, MING GUO, RONG-PING |
author_sort | XIAO, CHENG-ZUO |
collection | PubMed |
description | The present study aimed to identify the risk factors influencing the survival of patients with hepatocellular carcinoma (HCC) affected by portal vein tumor thrombus (PVTT), following hepatic resection, and to establish a prognostic model. Between March 2001 and May 2008, 234 cases of HCC with PVTT that underwent hepatic resection were randomly divided into experimental or validation groups. The association between the clinicopathological factors and disease-free survival (DFS) and overall survival (OS) was analyzed, and the significant factors involved were used to establish a prognostic model, which was then validated. Tumor rupture, number of tumors and macroscopic vascular invasion were observed to be independent risk factors of DFS and OS. In the prognostic model, the DFS and OS of low-, medium- and high-risk patients in the experimental group were observed to be significantly different, compared to those in the validation group. In conclusion, the present study established a prognostic model for patients with HCC affected by PVTT following hepatectomy, and demonstrated that the model may be used to guide the treatment of these patients and predict their prognosis. |
format | Online Article Text |
id | pubmed-4665632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-46656322015-12-31 A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection XIAO, CHENG-ZUO WEI, WEI GUO, ZHI-XING LI, SHU-HONG ZHANG, YONG-FA WANG, JIA-HONG SHI, MING GUO, RONG-PING Oncol Lett Articles The present study aimed to identify the risk factors influencing the survival of patients with hepatocellular carcinoma (HCC) affected by portal vein tumor thrombus (PVTT), following hepatic resection, and to establish a prognostic model. Between March 2001 and May 2008, 234 cases of HCC with PVTT that underwent hepatic resection were randomly divided into experimental or validation groups. The association between the clinicopathological factors and disease-free survival (DFS) and overall survival (OS) was analyzed, and the significant factors involved were used to establish a prognostic model, which was then validated. Tumor rupture, number of tumors and macroscopic vascular invasion were observed to be independent risk factors of DFS and OS. In the prognostic model, the DFS and OS of low-, medium- and high-risk patients in the experimental group were observed to be significantly different, compared to those in the validation group. In conclusion, the present study established a prognostic model for patients with HCC affected by PVTT following hepatectomy, and demonstrated that the model may be used to guide the treatment of these patients and predict their prognosis. D.A. Spandidos 2015-11 2015-09-03 /pmc/articles/PMC4665632/ /pubmed/26722243 http://dx.doi.org/10.3892/ol.2015.3677 Text en Copyright: © Xiao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles XIAO, CHENG-ZUO WEI, WEI GUO, ZHI-XING LI, SHU-HONG ZHANG, YONG-FA WANG, JIA-HONG SHI, MING GUO, RONG-PING A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection |
title | A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection |
title_full | A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection |
title_fullStr | A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection |
title_full_unstemmed | A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection |
title_short | A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection |
title_sort | prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665632/ https://www.ncbi.nlm.nih.gov/pubmed/26722243 http://dx.doi.org/10.3892/ol.2015.3677 |
work_keys_str_mv | AT xiaochengzuo aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT weiwei aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT guozhixing aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT lishuhong aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT zhangyongfa aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT wangjiahong aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT shiming aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT guorongping aprognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT xiaochengzuo prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT weiwei prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT guozhixing prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT lishuhong prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT zhangyongfa prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT wangjiahong prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT shiming prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection AT guorongping prognosismodelforpatientswithhepatocellularcarcinomaandportalveintumorthrombusfollowinghepaticresection |